Login to Your Account



Financings Roundup


Wednesday, August 8, 2012
• Isis Pharmaceuticals Inc., of Carlsbad, Calif., said it plans to offer $175 million in aggregate principal of convertible senior notes due 2019 in a private placement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription